Coach Mpilo

19/10/2026

04/09/2026

Here's to the coach AI just a click on your hand.
WhatsApp 087 373 1634 Tap to Start chatting: rb.gy/1154uu

11/08/2026

That one health question you've been avoiding, the one that lives rent-free in your head? You don't have to carry it alone. Here's your AI Coach Friend
WhatsApp 087 373 1634 Tap to Start chatting: rb.gy/1154uu

21/05/2026

We had to say it in English too 👀

That one health question you've been avoiding, the one that lives rent-free in your head?
You don't have to keep carrying it chomie.

Coach Mpilo is your FREE AI health coach on WhatsApp. Private. Confidential. No clinic queues, no judgement, no awkward vibes.

Ask about sexual & reproductive health, mental wellbeing, weird symptoms, period health, medication, nutrition… anything that's been on your mind 🫂

You'll feel so much better when you know, I promise ❤️

👉 Tap to start chatting: rb.gy/1154uu

Or WhatsApp "FREE" to 087 373 1634

Available 24/7. Always private. Always free. 💙

07/05/2026

Between work, family and everything else, kulula ukubeka impilo yakho ekugcineni.

Your questions get pushed aside…but they don’t disappear.

With Coach Mpilo, ungabuza noma yini, anytime, day or night.

That’s the power of having a free AI health coach on WhatsApp.

Ask about symptoms, impilo yocansi kanye nokzala, mental wellbeing, imithi, nutrition, or lifestyle concerns.

No appointments. No queues. No embarrassment.
Just answers, when you need them.

WhatsApp the word ‘ FREE’ to 087 373 1634 or tap here to start chatting:
https://wa.me/27873731634?text=Begin%20chatting%20[free1]

XOXA NOMA KUNINI, 24/7

05/05/2026

We often have health problems we ignore..

Not because they’re unimportant,kodwa ngenxa yokuthi le mibuzo ikwenza uzizwe ungakhululekile. They're too personal, or hard to say out loud.

Now there's a safe space for you to get answers. 💪🏽

Chat to an AI health coach on WhatsApp.
Free. Private. Confidential.

Ask questions about symptoms, impilo yocansi kanye nokuzala, mental well-being, imithi, nutrition, or lifestyle concerns.

Uzozizwa ungcono uma wazi.🫂

WhatsApp the word 'FREE' to 087 373 1634 or tap here to try it:
https://wa.me/27873731634?text=Begin%20chatting%20[free]

XOXA NOMA KUNINI, 24/7

20/04/2026

New Pill for HIV patients

A new pill that could replace years of exhausting daily medication routines for millions of people living with HIV has just cleared a major scientific milestone — and the results are giving researchers and patients real reason for hope.

Pharmaceutical company Gilead Sciences has developed a single tablet combining two medicines — bictegravir and lenacapavir — into one simple daily dose, and in clinical trials, patients who switched to it kept the virus at undetectable levels after 48 weeks, performing just as well as far more complex multi-pill regimens with no serious new side effects reported.

Currently, many people living with HIV take anywhere between 2 and 11 pills every single day — with nearly half requiring medication more than once daily — making consistency a constant challenge and missed doses a serious health risk.

If approved, this single tablet could deliver something significant — better adherence, fewer treatment interruptions, and far less daily burden for people who have spent years managing complex medication schedules just to stay healthy.

For millions of people living with HIV around the world, that progress could mark a turning point in long-term care, treatment consistency, and overall quality of life.

Sources: Gilead Sciences | ARTISTRY Phase 3 Trials

15/04/2026

Let's talk TB today

Tuberculosis (TB) is caused by the bacterium Mycobacterium tuberculosis. While TB is usually treatable with a standard course of medicines, multidrug-resistant TB (MDR-TB) develops when the bacteria no longer respond to the two most effective first-line drugs: isoniazid and rifampicin. This makes treatment more complicated, longer, and often more difficult for patients.

🔎 Key Facts about MDR-TB

• MDR-TB is a form of TB that resists the most powerful medicines used in standard treatment.
• Globally, over 410,000 people developed MDR-TB or rifampicin-resistant TB in 2022.
• Treatment success rates are improving but remain alarmingly low compared to drug-sensitive TB.
• Some strains are even more resistant, called extensively drug-resistant TB (XDR-TB), which resist additional second-line medicines.

💡 Why it Matters
MDR-TB is not just a medical challenge—it’s a social one. Patients often face stigma, isolation, and barriers to accessing care. Without proper treatment, MDR-TB can spread and threaten communities worldwide.

✨ Hope and Action
Despite the challenges, people with MDR-TB can recover. New medicines, better diagnostic tools, and strong support systems are making treatment more effective. At tbpeople, we stand with those affected, amplify their voices, and advocate for access to care and dignity.

13/04/2026

Just like you prevent a pregnancy by taking an emergency pill is the same way you can prevent HIV by taking PEP within 3days(72 hours) from exposure.

10/04/2026

QUERY OF THE WEEK:
We received a call from a doctor in Gauteng asking about ART for a baby boy. The baby was born at 39 weeks weighing 2.6 kg and was receiving AZT+NVP for VTP.

The baby's birth PCR was positive but he was not brought in for a first post-natal visit (3-6 days). The mother was urgently traced but only brought him in today. He is now is 4 weeks old and weighs 2.8 kg.

The doctor was unsure of what to do?

ANSWER:
The baby should be switched from VTP (prophylaxis) to ART (treatment) immediately. The recommended regimen is ABC+3TC+DTG.

For infants that are > 2 kg and ≥ 37 weeks gestational age, ABC+3TC+DTG is recommended.

This case highlights the importance of the first postnatal visit at 3-6 days after delivery, to check the birth PCR result.

If you need help with your HIV- and/or TB-infected patients, feel free to phone 0737926342